by Ketamine Greater Boston | Jan 25, 2021 | KETAMINE FOR DEPRESSION
When we take a step back and look at all the research that is being conducted around the use of ketamine for depression, it is absolutely remarkable. It seems as though each and every day a new facet of the drug is being put under a microscope. With this being said,...
by Ketamine Greater Boston | Jan 11, 2021 | KETAMINE FOR DEPRESSION
Much of the research—so far—about the impact of the Covid-19 pandemic on mental health has been focused on healthcare workers and the general public. However, new studies are taking a deeper look at the mental health impact on individuals with COVID-19. Early findings...
by Ketamine Greater Boston | Jan 3, 2021 | KETAMINE FOR DEPRESSION
In early 2019, the FDA approved esketamine (marketed as Spravato™) as an additional therapy option for the management of treatment-resistant depression. Like its parent compound, ketamine, Spravato aids in the restoration of synaptic connections in the brain, which is...
by Ketamine Greater Boston | Dec 4, 2020 | KETAMINE FOR DEPRESSION
Researchers have been exploring how gratitude can improve mental health for years now. They’ve found that it could actually alleviate depression symptoms in some people. Practicing gratefulness has a huge impact on our mindset, and it is not that being happy makes us...
by Ketamine Greater Boston | Nov 9, 2020 | KETAMINE FOR DEPRESSION
Seasonal Affective Disorder (SAD) is a type of recurrent depression that many people suffer from, and it can look a lot like clinical depression. SAD was first identified by Dr. Normal E. Rosenthal in 1980, and it is estimated that 5% of the population (or one in 20...
Recent Comments